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Abstract 
Objectives: The aim of this study was to determine the effects of escalation of 
respiratory support and prolonged postoperative invasive ventilation on patient–
centered outcomes, and identify perioperative factors associated with these two 
respiratory complications.  
Design: A retrospective cohort analysis of cardiac surgical patients admitted to 
cardiothoracic intensive care unit (ICU) between August 2015 and January 2018. 
Escalation of respiratory support was defined as ‘unplanned continuous positive 
airway pressure’, ‘non-invasive ventilation’ or ‘reintubation’ following surgery; 
prolonged invasive ventilation was defined as ‘invasive ventilation beyond the first 12 
hours following surgery’. The primary endpoint was the composite of escalation of 
respiratory support and prolonged ventilation.  
Setting: Tertiary cardiothoracic ICU. 
Participants: A total of 2,098 patients were included and analyzed.  
Interventions: None. 
Measurements and Main Results: The composite of escalation of support or 
prolonged ventilation occurred in 509 patients (24.3%). Patients who met the 
composite had higher mortality (2.9% vs 0.1%; P<0.001) and longer median 
[interquartile range] length of ICU  (2.1 [1.0–4.9] vs 0.9 [0.8–1.0] days; P<0.0001) 
and hospital (10.6 [8.0–16.0] vs 7.2 [6.2–10.0] days; P<0.0001) stay. Hypoxemia and 
anemia on admission to ICU were the only two factors independently associated with 
need for escalation of respiratory support or prolonged invasive ventilation. 
Conclusions: Escalation of respiratory support or prolonged invasive ventilation are 
frequently seen in cardiac surgery patients, and are highly associated with increased 
mortality and morbidity. Hypoxemia and anemia on admission to ICU are potentially 
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modifiable factors associated with escalation of respiratory support or prolonged 
invasive ventilation. 
Key Words: cardiac surgery; postoperative pulmonary complications; pulmonary 
morbidity; invasive ventilation 
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Introduction 
A new consensus definition of ‘postoperative pulmonary complications’ has been 
recently proposed by the ‘Standardized Endpoints for Perioperative Medicine’ (StEP) 
Collaboration.1 This consensus definition consists of four rather subjective pulmonary 
outcome measures, namely atelectasis, pneumonia, aspiration, and the acute 
respiratory distress syndrome.1,2 The StEP Collaboration also introduced a concept 
of ‘severity’ of pulmonary complications after surgery, which may reduce the 
subjectivity of the definition.1,2 In their consensus, severity is classified as ‘severe’ 
when a patient needs escalation of respiratory support, defined as ‘unplanned 
continuous positive airway pressure’ (CPAP), ‘unplanned non-invasive ventilation’ 
(NIV), or ‘reintubation and invasive ventilation’.1 
 
As with other major surgeries, cardiac surgery is associated with postoperative 
pulmonary morbidity associated with adverse clinical outcomes such as increased 
mortality and prolonged hospital stay, and also increased healthcare utilization 
costs.3,4 Postoperative pulmonary complications in the context of cardiac surgery 
have been poorly defined and cardiac surgery–specific factors such as the use of 
cardiopulmonary bypass and apnea during cardiopulmonary bypass, intraoperative 
manipulation of the lungs and thoracic cage, and midline sternotomy appear to 
increase the risk for pulmonary complications after surgery.5, 6 
 
The StEP Collaboration approach has not yet been explored in a cardiac surgical 
population.3,4 The current study aimed to quantify the rate of escalation of respiratory 
support (as defined by StEP Collaboration for ‘severe’ pulmonary complications) or 
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prolonged postoperative invasive ventilation (not used by the StEP Collaboration, but 
yet another frequent and unwanted respiratory complication after cardiac surgery), 
and determine their relation with mortality and morbidity. In addition, perioperative 
factors predictive of escalation of respiratory support or prolonged invasive ventilation 
were identified. Establishing the severity of respiratory complications after cardiac 
surgery, and potentially modifiable risk factors associated with their development, will 
eventually allow development and evaluation of mitigation strategies. Our null 
hypothesis was therefore that StEP-defined severe postoperative pulmonary 
complications and prolonged postoperative invasive ventilation are not associated 
with adverse outcomes of mortality and ICU length of stay. 
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Methods 
We retrospectively examined a cohort of adult cardiac surgical patients who 
underwent elective cardiac surgery with cardiopulmonary bypass (first–time coronary 
artery bypass grafting, valve surgery or combined coronary artery bypass with valve 
surgery) and were admitted to Royal Papworth Hospital National Health Service 
(NHS) Trust cardiothoracic intensive care unit (a leading heart and lung center in 
Cambridgeshire, UK and one of the largest specialist cardiothoracic hospitals in 
Europe), between August 2015 and January 2018. The study period was selected 
based on the fact that were no changes to standard patient management procedures 
during this period, minimizing a potentially significant source of bias. Patients who 
underwent redo–sternotomy, post–cardiotomy cardiac or respiratory extracorporeal 
membrane oxygenation or other procedures (‘off pump’ surgery, aortic root surgery, 
heart or lung transplantation, septal defect surgery, and vascular reconstruction) 
were excluded.  
        
The analysis and reporting adhered to the Strengthening the Reporting of 
Observational Studies in Epidemiology (STROBE) statement.7 The project proposal 
was reviewed and approved by the Royal Papworth Hospital NHS Foundation Trust 
Research and Development board (S02402, correspondence 14/03/2018), it was 
deemed to have no material ethical issues and written informed consent was not a 
requirement. All data were depersonalized and anonymized. 
 
Data was collected via the perioperative surgical and intensive care unit (ICU) 
electronic clinical information systems and the local clinical audit and research data 
system. 
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Escalation of respiratory support was defined as described by the StEP 
Collaboration1, as follows: 
1. need for unplanned postoperative use of CPAP, or 
2. need for unplanned postoperative NIV, or 
3. need for reintubation and invasive ventilation 
Prolonged invasive ventilation was defined as need for invasive ventilation beyond 12 
hours after surgery.8-1 
 
Intensive care unit and hospital mortality were defined as death during the time they 
were in the ICU or in the hospital. Length of stay in ICU was defined as time between 
point of entry to the ICU to discharge back to the cardiac surgery ward, or time of 
mortality in ICU if this occurred. Hospital length of stay refers to the day of surgery to 
last day in hospital alive. 
 
The local intraoperative and postoperative strategies during the study period were 
not rigid, but comprised strong advice to use tidal volumes of 6–8 ml/kg-1 predicted 
body weight; positive end–expiratory pressure (PEEP) level of 5 cm H2O without 
routine use of alveolar recruitment maneuvers; and cessation of mechanical 
ventilation and zero PEEP during cardiopulmonary bypass.11 The intraoperative red 
cell transfusion threshold was 70 g/L. Postoperative management in the ICU 
consisted of cardiac monitoring, and optimization of hemodynamics. Weaning of 
ventilatory support, transition from assist ventilation to spontaneous ventilation, and 
extubation were conducted when patients met appropriate criteria namely 
normothermia, absence of bleeding, established regular spontaneous respiratory 
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pattern, hemodynamic stability, and no residual neuromuscular blockade or abnormal 
neurological findings. 
 
Decisions to escalate respiratory support or to continue invasive mechanical 
ventilation was at the discretion of the attending intensivist. High–flow nasal oxygen 
therapy was only seldomly used at the time of this study. 
 
Baseline patient characteristics including gender, age, weight, height, body mass 
index, type of cardiac surgery, logistic and additive European System for Cardiac 
Operative Risk Evaluation (EuroSCORE)12 were extracted from the electronic clinical 
information system and the local clinical audit and research data system. 
Perioperative data (cardiopulmonary bypass time, cross-clamp time, and duration of 
invasive ventilation) were derived from the local clinical audit and research data 
system. Hemoglobin levels and ratio of arterial partial pressure of oxygen to inspired 
fraction of oxygen on admission to ICU were extracted from the electronic clinical 
information system. Escalation of respiratory support in the first five postoperative 
days, survival, and length of stay data were derived from the local electronic clinical 
information, clinical audit and research data systems. 
 
 
The primary endpoint of the study was the composite of ‘need for escalation of 
respiratory support’ and ‘prolonged invasive ventilation’. The composite of 
postoperative escalation of respiratory support, as defined by StEP collaboration and 
prolonged invasive ventilation was chosen as the primary endpoint as it integrates 
both intraoperative (e.g., ventilator–induced lung injury, transfusion associated lung 
         
11 
 
injury, and transfusion associated circulatory overload) and postoperative 
complications (e.g., atelectasis); our composite outcome is therefore a ‘non–mortality’ 
outcome reflecting quality of perioperative care which makes it more meaningful to 
patients, healthcare providers and the public than specific physiological pulmonary 
outcomes or individual postoperative pulmonary complications.1,2,13 
 
Secondary outcomes were the risk of mortality and length of stay in ICU and hospital. 
Other outcomes were mediating perioperative factors contributing to the primary 
outcome. 
 
Statistical Analysis 
Where appropriate, continuous data between groups were compared using either the 
student t–test (mean comparison) or Wilcoxon Rank Sum (median comparison) and 
categorical data were compared using chi-squared tests. Where dependent variables 
were continuous, an adjusted generalized linear regression model was used to 
assess the impact of a unit of change per dependent variable described as a 
regression coefficient. Alternatively, where dependent variables were binary an 
adjusted logistic regression was conducted to assess the unit of change as an odds 
ratio (OR). The composite outcome consisting of patients who required escalation of 
respiratory support or prolonged invasive ventilation was described using the 
frequency of patients rather than treated as separate events to prevent multiple 
counting of the same individual (e.g. to prevent individuals who were intubated for 
over 12 hours and required post–extubation CPAP being counted twice). 
Time dependent data such as 'time to extubation’, and lengths ICU and hospital stay 
were presented using Kaplan–Meier analyses comparing patients who required 
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escalation of respiratory support or prolonged invasive mechanical ventilation against 
those who did not require these interventions. 
 
Risk factors were identified contributing to the development of either a requirement 
for escalation of respiratory support or a prolonged invasive ventilation. The models 
identifying risk factors were developed in accordance with transparent reporting of a 
multivariable prediction model for individual prognosis or diagnosis (TRIPOD) 
guidelines.14 Potential risk factors based on demographic and physiological data 
were prespecified based on a review of the literature and data availability. An 
unadjusted association between potential risk factors and need for escalation of 
respiratory support or prolonged invasive ventilation was assessed using univariate 
logistic regression. A liberal P–value threshold of < 0.15 was set as the cut–off point 
following univariate regression to select variables for inclusion in the multiparametric 
model. Statistical significance in the multivariate model was set at a P–value < 0.05. 
Where missing data were present in variables of interest a complete-case analysis 
was conducted when developing the regression model, as very few cases had any 
missing data (n=9). 
 
Following development of a regression model, the multivariate model was internally 
assessed using bootstrap methods. Each model created was validated on 100 
replications using the bootstrap method. These results were then visually compared 
to the main analysis to assess for any differences in performance. 
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All analyses were performed using Stata version 14.2 (StataCorp. 2015. Stata 
Statistical Software: Release 14. College Station, TX: StataCorp LLC) software. A P–
value < 0.05 was considered statistical significance. 
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Results 
Study Population 
Of 4,732 patients admitted, 2,098 patients met the inclusion criteria (Figure 1). 
Baseline characteristics and outcomes are presented in Tables 1 and 2. The majority 
of patients were male and underwent coronary artery bypass graft surgery. The 
median [interquartile range (IQR)] time to extubation was 6.1 [4.0–11.0] hours. 
 
Escalation of Respiratory Support or Prolonged Invasive Ventilation 
Rate of escalation of respiratory support in the first five postoperative days was 7.3% 
and rate of prolonged invasive ventilation was 22.8% (Table 2). The rate of the 
composite of escalation of respiratory support or prolonged invasive ventilation was 
24.3%. 
 
Patients who met the composite had a longer median time to extubation (23 [14–61] 
vs 5 [3–7] hours; P<0.0001), longer median ICU (2.1 [1.0–4.9] vs 0.9 [0.8–1.0] days; 
P<0.0001) and hospital (10.6 [8.0–16.0] vs 7.2 [6.2–10.0] days]; P<0.0001) stay 
(Table 3, Figure 2). A subgroup analysis is presented in supplementary material 
section (Figure 3) where the composite group is broken down into patients who 
required escalation of respiratory support and patients who received prolonged 
invasive ventilation. ‘Time to extubation’, ‘time to discharge from ICU’ and ‘time to 
discharge from hospital’ were longer in patients with either complication. 
 
After adjusting for possible confounding factors, including EuroSCORE, 
cardiopulmonary bypass time, age, gender, body mass index, cross–clamp time, ICU 
admission hemoglobin level, admission arterial partial pressure of oxygen to inspired 
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fraction of oxygen ratio, and type of surgery, there was a significant between–group 
difference in length of ICU stay [regression coefficient 3.0 (95% CI, 1.3–4.8)], hospital 
length of stay [regression coefficient 10.0 (95% CI, 5.8–14.3)], and in–hospital 
mortality (2.9% vs 0.1 %; P< 0.001). 
 
Risk Factors for Escalation of Respiratory Support or Prolonged Invasive Ventilation 
The results of the unadjusted univariate logistic regression are summarized in Tables 
4 and 5. Additional data on levels of oxygenation and internal validation using 
bootstrap replication are shown in supplementary material (Appendix A, e-Tables 1-
3).15 Multivariable adjustment showed that the hemoglobin level (OR 0.98 [0.97–
0.99]; P=0.002) and the arterial partial pressure of oxygen to inspired fraction of 
oxygen ratio (OR 0.92 [0.90–0.94]; P<0.001) directly after surgery were significant 
risk factors for subsequent escalation of respiratory support. These factors remained 
congruent following bootstrap validation. 
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Discussion 
Escalation of respiratory support or invasive ventilation beyond 12 hours after cardiac 
surgery was associated with adverse clinical outcomes of increased mortality and 
prolonged ICU and hospital length of stay, which are outcomes of interest to patients 
and relatives as well as clinicians and healthcare organizations. This was 
demonstrated in an unselected patient population, which suggests that the StEP 
collaboration criteria combined with prolonged ventilation are useful for routine 
surveillance, and may form the metric for quality improvement work in this area. 
Unsurprisingly, within this cohort, patients undergoing more complex surgery (as 
defined by longer cardiopulmonary bypass time) and more comorbid patients (higher 
EuroSCORE) were at higher risk of need for escalation of respiratory support or 
prolonged invasive ventilation, a finding that adds clinical plausibility to the measure. 
 
It is likely that occurrence of escalation of respiratory support reflects one or more 
severe postoperative pulmonary complications leading to severe respiratory 
insufficiency. The StEP Collaboration criteria for severity of respiratory complications 
after surgery are objective measures which are not susceptible to criteria based on a 
clinical diagnosis. Indeed, diagnosing pneumonia can be complex, and simple factors 
such as not using chest radiography routinely or changes in microbiological sampling 
techniques can alter the reported rates of diagnosis.16 
 
One retrospective study of 1,225 cardiac surgical patients found that the rate of 
unplanned NIV use was 5.1%, which is in line with our findings (6.0%). However, that 
study had a smaller sample size and reported reintubation rates in the context of NIV 
failure only.17 
         
17 
 
We demonstrated that hypoxemia and anemia on admission to ICU are associated 
with escalation of respiratory support or prolonged invasive ventilation. The arterial 
partial pressure of oxygen to inspired fraction of oxygen ratio has been shown to 
predict mortality in the cardiac surgical setting.18 Its usefulness as a predictor of 
escalation of respiratory support or prolonged invasive ventilation has not been 
described before. Perioperative anemia, defined as hemoglobin < 100 g/L, leads to a 
3–fold increase in risk for postoperative pulmonary complications, independent of 
type of surgery.19, 20 Anemia in the context of cardiac surgery is associated with 
adverse postoperative outcomes although in moderate to high risk cardiac surgical 
patients a restrictive transfusion strategies (hemoglobin < 75g/L) are non-inferior to 
liberal transfusion thresholds.21-23The causal link between postoperative anemia and 
respiratory complications after surgery is yet uncertain. However, one might 
hypothesize that need for escalation of respiratory support or prolonged invasive 
ventilation can be explained by higher blood transfusion requirements in anemic 
patients potentially resulting in transfusion–related lung injury or circulatory 
overload.24, 25 Of note, it was impossible to include intraoperative ventilatory variables 
like PEEP or other parameters of pulmonary mechanics such as driving pressure or 
mechanical power since these data were not available. Future studies should aim to 
obtain such data as they may be significant predictors of respiratory complications 
after surgery, and if so whether they are modifiable. 
 
Several authors have reported outcomes related to prolonged invasive ventilation 
after cardiac surgery and developed prediction models mainly using 24–, 36– or 48–
hour thresholds for prolonged invasive ventilation.26-33 The standard definition of 
prolonged invasive ventilation according the Society of Thoracic Surgeons (STS) is a 
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duration exceeding 24 hours.13 It has been shown that ‘time to extubation’ after 
cardiac surgery longer than 16 hours predicts poor clinical outcomes (morbidity, 
mortality and reintubation) and that liberation from the ventilator within the first nine 
hours is a predictor of better postoperative outcomes.34-36 Recent evidence suggests 
that extubation after 12–hours is associated with poor outcomes and that major 
morbidity, operative mortality, and prolonged length of stay after cardiac surgery do 
not significantly increase until ‘time to extubation’ exceeds 12 hours.8-10 On this basis, 
here the 12–hour benchmark was incorporated as an indicator of prolonged invasive 
ventilation into the composite.  
 
In addition to prolonged cardiopulmonary bypass time and aortic cross–clamp time 
(known risk factors for prolonged invasive mechanical ventilation beyond 24 hours), 
anemia and hypoxemia on admission to ICU were identified as risk factors for 
prolonged invasive ventilation.37-40 As an observational study we cannot determine 
the mechanisms which lead to the associations found, however from the literature we 
can hypothesize that long cardiopulmonary bypass time can lead to pulmonary 
dysfunction and need for prolonged invasive ventilation through the following 
mechanism: systemic inflammatory response and activation of proinflammatory 
cytokines leading to endothelial damage, increased pulmonary capillary permeability 
and extravascular lung water affecting lung compliance and gas exchange.41 
Similarly, the association between prolonged aortic cross–clamp time and delayed 
extubation could reflect pulmonary microvascular dysfunction, although the 
mechanistic link between ischemia-reperfusion and lung injury is not well understood. 
It is assumed that it is related to an increase in pulmonary vascular resistance and 
capillary permeability caused by prostaglandins, free radicals and complement 
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activation.42 The association between postoperative anemia and prolonged 
ventilation may reflect postoperative bleeding and as a result maintenance of 
sedation and invasive ventilation in case reoperation is needed. Hypoxemia may be 
due to one or more postoperative pulmonary complications (e.g., atelectasis, 
ventilator–induced lung injury). Hypoxemia would ordinarily delay tracheal extubation 
until lung tissue is re–recruited and oxygenation is considered adequate. 
 
The strengths of our study lie in using a large dataset with high level of 
completeness, the fact that there was no change in practice during the study period, 
the robust outcome measures with minimal scope for subjectivity, and the excellent 
follow-up rates. In addition, we were able to conduct internal validation of our 
predictive model using bootstrapping demonstrating internal reliability of our findings. 
 
Certain limitations to our study should be acknowledged. First, its retrospective 
design renders the study susceptible to selection bias and only data which is 
recorded routinely was available, limiting our ability to analyze factors such as intra-
operative ventilation or report on individual postoperative pulmonary complications 
(atelectasis,  
pneumonia, acute respiratory distress syndrome, pulmonary aspiration).1, 2 In 
addition, due to the observational nature of the study it was not possible to control for 
clinical decision making; however, agreed standards and protocol–driven care 
minimize variations in individual practice within the institution where our study took 
place. In our modelling examining the length of stay, we were unable to account for 
early mortality in both groups. Although, the number of patients who died during the 
study period was low (n=16), this may introduce a possible censoring bias which 
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should be considered in studies. Second, the study was undertaken at a large 
volume cardiothoracic center and the risk factor analysis was not externally validated 
on other data sets; therefore, our results are not necessarily generalizable nor 
transportable to other settings or geographical areas. Third, it was not possible to 
include fluid balance, volumes and types of transfused blood products, hemodynamic 
variables or vasoactive drug data which could potentially be related to risk factors 
causing planned or unplanned prolonged invasive ventilation (e.g., delayed 
extubation due to significant hemodynamic instability, hemorrhage and/or high 
vasoactive drug requirements or volume overload affecting gas exchange) and 
escalation of respiratory support (in cases of low cardiac output state and cardiac 
failure). Finally, other confounding factors such as peri-operative respiratory tract 
infections, heavy smoking history, pre-existing lung disease,43 acute onset atrial 
fibrillation, slow recovery from anesthesia or acute neurological deficit, could 
potentially have a hidden effect on our collapsed composite outcome. 
 
Having validated the StEP criteria for severity of postoperative pulmonary 
complications in a cardiac surgical population, we propose a number of possible uses 
for this approach. The key question is whether pulmonary complications after surgery 
are preventable, and if so whether their prevention improves patient–focused 
outcomes. Potential interventions to test include: early extubation thresholds (e.g., 6– 
or 12–hours) as recent data suggested no detrimental effect of extubation by 6 hours 
8, 10, perioperative oxygenation targets, effect of perioperative transfusion strategies 
and intraoperative ventilatory strategies, including PEEP and alveolar recruitment 
maneuvers. If our risk–adjustment is validated in subsequent studies, it may offer a 
method for producing risk–adjusted postoperative pulmonary complications rates 
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allowing effective prospective comparison within and between units, facilitating the 
use of postoperative pulmonary complications rates as a quality measure. 
 
Conclusion 
In a low to medium risk patient population undergoing routine cardiac surgery, 
escalation of respiratory support or prolonged invasive ventilation are associated with 
adverse outcomes. Hypoxemia and anemia after cardiac surgery are potentially 
modifiable risk factors for pulmonary complications, which need to be better 
addressed in future studies. 
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Figure Legends 
 
Figure 1. Flow diagram of study population. 
 
Figure 2. Time to event curves for patients with and without the composite outcome 
(Panels A-C)   
Panel A - time alive whilst receiving invasive mechanical ventilation  
Panel B - time alive and remaining in intensive care unit 
Panel C - time alive and remaining in hospital 
Escalation of respiratory support (StEP criteria) was defined as unplanned 
continuous positive airway pressure, non–invasive ventilation or reintubation and 
invasive ventilation. Prolonged ventilation was defined as invasive mechanical 
ventilation for more than 12 hours after exit from operation room. 
StEP, Standardized Endpoints for Perioperative Medicine 
 
Figure 3. Time to event curves for patients with and without StEP-defined pulmonary 
complications (Panels A-C) and for patients receiving immediate postoperative 
invasive mechanical ventilation for >12 and <12 hours (Panels D-F)  
Panel A and D -time alive whilst receiving mechanical ventilation  
Panel B and E- time alive and remaining in intensive care unit 
Panel C and F- time alive and remaining in hospital 
Escalation of respiratory support (StEP criteria) was defined as unplanned 
continuous positive airway pressure, non–invasive ventilation or reintubation and 
invasive ventilation. Prolonged ventilation was defined as invasive mechanical 
ventilation for more than 12 hours after exit from operation room. 
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StEP, Standardized Endpoints for Perioperative Medicine 
Appendix A. Supplementary Data  
e-Table 1. Table showing initial postoperative arterial partial pressure of oxygen to 
inspired fraction of oxygen ratios on admission to intensive care unit.  
e-Table 2. Table showing internal validation using bootstrap replication for escalation 
of respiratory support multivariate model. 
e-Table 3. Table showing internal validation using bootstrap replication for the 
prolonged invasive ventilation multivariate model.  
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Table 1. Patient characteristics.  
Patient characteristics 
 
Study cohort (n= 2,098) 
Age (years) 69.8 (10.7) 
Sex  
Male 1498 (71.4%) 
Height (meters) 
 
1.70 (0.10) 
Weight (kg) 
 
82 [71 to 93] 
BMI (kg/m2) 
 
28.5 (5.2) 
Hemoglobin (g l-1) 
 
103.4 (15.9) 
Logistic EuroSCORE 
 
4.0 [2.1 to 7.5] 
Additive EuroSCORE 
 
5 [3 to 7] 
Time to extubation (hours) 
 
6.14 [4.04 to 11.02] 
 
Surgical characteristics 
 
Type of surgery  
 
CABG  
919 (43.8%) 
Valve surgery  786 (37.5%) 
CABG and valve surgery 
 
393 (18.7%) 
 
Cardiopulmonary bypass time (minutes) 
 
 
85 [68 to 105] 
Cross clamp time (minutes) 57 [44 to 72] 
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Data are mean (SD), number (%) or median [interquartile range].  
Abbreviations: BMI, body mass index; CABG, coronary artery bypass graft; 
EuroSCORE, European System for Cardiac Operative Risk Evaluation; n, number; 
SD, standard deviation 
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Table 2. The occurrence of escalation of respiratory support and prolonged invasive 
ventilation within the first 5 postoperative days 
Outcome 
 
Frequency of event 
(n=2098) 
Percentage (%) 
CPAP/NIV  
 
126 6.0 
Reintubation  
 
40 1.9 
Prolonged invasive 
ventilation (> 12 hours) 
 
478 23 
Composite outcome 
groups 
  
 
Escalation of respiratory 
support (requiring 
CPAP/NIV or reintubation 
and invasive ventilation-
StEP defined severe 
pulmonary complications) 
 
 
154 7.3 
Escalation of respiratory 
support (requiring 
CPAP/NIV or reintubation 
and invasive ventilation) 
and/or prolonged invasive 
ventilation (> 12 hours) 
 
 
510 24.3 
 
Data are frequencies of patients experiencing the outcomes and percentages (the 
composite outcome consisting of patients who required escalation of respiratory 
support or prolonged invasive ventilation was described using the frequency of 
patients rather than treated as separate events to prevent multiple counting of the 
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same individual (e.g. to prevent individuals who were intubated for over 12 hours and 
required post–extubation CPAP being counted twice) 
Abbreviations: CPAP, continuous positive airway pressure; NIV, non-invasive 
ventilation; StEP, Standardized Endpoints for Perioperative Medicine 
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Table 3. Characteristics of patients requiring escalation of respiratory support or 
invasive mechanical ventilation for more than 12 hours after exit from operation room 
(Escalation of respiratory support12 group) vs. the rest of the cohort (No escalation of 
respiratory support group).  
Variable Escalation of 
Respiratory 
Support12 (n=510) 
No 
escalation of 
respiratory 
support 
(n=1588) 
P value 
 
Surgical 
characteristics 
   
Type of surgery 
 
   
CABG  211 (41%) 708 (45%)  
Valve surgery 159 (31%) 627 (40%)  
CABG and valve surgery 140 (28%) 253 (16%) <0.001 
    
Cardiopulmonary bypass 
time (minutes) 
92.5 [73 to 120] 84 [66 to 
101.5] 
<0.0001 
Cross clamp time 
(minutes) 
 
61 [47 to 82] 56 [44 to 70] <0.0001 
 
Patient characteristics 
   
Age (years) 71.5 (10.4) 69.2 (10.8) <0.0001 
 
Sex 
   
Male 
 
357 (70%) 1588 (72%)  
Height (metres) 
 
1.69 (0.10) 1.70 (0.10) 0.0989 
Weight (kg) 
 
83 [71 to 97] 81 [71 to 92] 0.0247 
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BMI (kg/m2) 
 
29.4 (6.0) 28.2 (4.9) <0.0001 
 
Hemoglobin (g l-1) 
mean (SD) 
 
99.8 (17.2) 
 
104.6 (15.2) 
 
<0.0001 
Logistic EuroSCORE 5.1 [2.5 to 9.2] 3.7 [2.1 to 
6.7] 
<0.0001 
Additive EuroSCORE 6 [4 to 8] 5 [3 to 7] <0.0001 
PaO2:FiO2 ratio 30.5 [22.1-39.0] 35.3 [28.4-
42.7] 
<0.0001 
 
Outcomes 
   
ICU length of stay (days) 2.1 [1.0 to 4.9] 0.9 [0.80 to 
1.0] 
<0.0001 
Hospital length of stay 
(days) 
 
10.6 [8.0 to 16.0] 7.2 [6.2 to 
10.0] 
<0.0001 
Time to extubation 
(hours) 
23 [14 to 61]  5 [3 to 7] <0.0001 
In-hospital mortality  15 (2.9%) 1 (0.1%) <0.001 
Data are mean (SD), number (%) or median [interquartile range]. The reported P 
values were derived from t-test (means), Wilcoxon rank sum test (medians), and chi-
squared test (categorical data).  
Abbreviations: BMI, body mass index; CABG, coronary artery bypass graft; 
EuroSCORE, European System for Cardiac Operative Risk Evaluation; ICU, 
intensive care unit; n, number; SD, standard deviation; PaO2:FiO2 ratio, ratio of 
arterial partial pressure of oxygen to inspired fraction of oxygen 
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Table 4. Table showing univariable and multivariable regression of risk factors for 
postoperative escalation of respiratory support (StEP criteria).  
Variable of 
Interest 
Univariate 
analysis 
P value Included in 
multivariate 
model (P  
value<0.15) 
Multivariate 
Analysis 
P value 
 Unadjusted 
odds ratio 
(95% CI) 
  Odds ratio 
(95% CI) 
 
Age 1.00 (0.99 to 
1.02) 
0.669 No - - 
Sex (Male=1) 1.34 (0.91 to 
1.97) 
0.137 Yes 0.98 (0.56 to 
1.70) 
0.930 
Height 2.52 (0.44 to 
14.42) 
0.299 No - - 
Weight 1.03 (1.02 to 
1.04) 
<0.001 Yes 1.01 (0.99 to 
1.03) 
0.381 
BMI 1.10 (1.07 to 
1.13) 
<0.001 Yes 1.03 (0.96 to 
1.11) 
0.380 
Hemoglobin 0.99 (0.98 to 
1.00) 
0.096 Yes 0.98 (0.97 to 
0.99) 
0.002 
 
Type of Surgery 
- - Yes - - 
CABG  Ref Ref - Ref Ref 
Valve Surgery  0.49 (0.33 to 
0.73) 
0.001 - 0.67 (0.41 to 
1.09) 
0.108 
CABG and Valve 
Surgery 
1.03 (0.68 to 
1.55) 
0.890 - 0.76 (0.43 to 
1.33) 
0.339 
Logistic 
EuroSCORE 
 
1.01 (0.98 to 
1.04) 
0.322 No - - 
Additive 
EuroSCORE 
 
1.02 (0.96 to 
1.08) 
0.625 No - - 
 
Cardiopulmonary 
bypass time 
 
1.01 (1.00 to 
1.01) 
<0.001 Yes 1.00 (0.99 to 
1.02) 
0.478 
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Cross clamp time 1.01 (1.00 to 
1.01) 
0.005 Yes 1.00 (0.98 to 
1.02) 
0.865 
HFNO 0.97 (0.13 to 
7.28) 
0.979 No - - 
PaO2:FiO2 ratio 0.90 (0.89 to 
0.92) 
<0.001 Yes 0.91 (0.89 to 
0.93) 
<0.001 
Abbreviations: BMI, body mass index; CABG, coronary artery bypass graft; CI, 
confidence interval; EuroSCORE, European System for Cardiac Operative Risk 
Evaluation; HFNO, high-flow nasal oxygen; PaO2:FiO2 ratio, arterial partial pressure 
of oxygen to inspired fraction of oxygen ratio; Ref, reference; StEP, Standardized 
Endpoints for Perioperative Medicine 
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Table 5. Table showing univariable and multivariable regression of risk factor for 
prolonged invasive ventilation.  
Variable of 
Interest 
Univariate 
analysis 
P value Included in 
multivariate 
model (P 
value <0.15) 
Multivariate 
Analysis 
P value 
 Unadjusted 
odds ratio 
(95% CI) 
  Odds ratio 
(95% CI) 
 
Age 1.02 (1.01 
to 1.03) 
<0.001 Yes 1.00 (0.98 to 
1.01) 
0.666 
Sex (Male=1) 0.89 (0.71 
to 1.11) 
0.284 No - - 
Height 0.37 (0.13 
to 1.08) 
0.069 Yes 0.75 (0.00 to 
303.0) 
0.926 
Weight 1.01 (1.00 
to 1.01) 
0.016 Yes 1.00 (0.94 to 
1.06) 
 
0.967 
BMI 1.04 (1.02 
to 1.06) 
<0.001 Yes 1.03 (0.87 to 
1.22) 
0.726 
Hemoglobin 0.98 (0.97 
to 0.99) 
<0.001 Yes 0.98 (0.97 to 
0.99) 
<0.001 
 
Type of surgery 
  Yes - - 
CABG Ref Ref - Ref Ref 
Valve Surgery 0.88 (0.69 
to 1.11) 
0.294 Yes 0.96 (0.68 to 
1.34) 
0.796 
 
CABG and Valve 
Surgery 
1.99 (1.53 
to 2.59) 
<0.001 Yes 1.10 (0.74 to 
1.65) 
0.613 
Logistic 
EuroSCORE 
 
1.06 (1.04 
to 1.08) 
<0.001 Yes 1.03 (0.99 to 
1.07) 
0.109 
Additive 
EuroSCORE 
 
1.15 (1.10 
to 1.19) 
<0.001 Yes 1.08 (0.96 to 
1.21) 
0.214 
 
Cardiopulmonary 
bypass time 
1.01 (1.01 
to 1.02) 
<0.001 Yes 1.02 (1.01 to 
1.03) 
<0.001 
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Cross clamp time 1.01 (1.01 
to 1.02) 
<0.001 Yes 0.99 (0.98 to 
1.00) 
0.032 
PaO2:FiO2 ratio 0.96 (0.95 
to 0.97) 
<0.001 Yes 0.96 (0.95 to 
0.97) 
<0.001 
 
Abbreviations: BMI, body mass index; CABG, coronary artery bypass graft; CI, 
confidence interval; EuroSCORE, European System for Cardiac Operative Risk 
Evaluation; PaO2:FiO2 ratio, arterial partial pressure of oxygen to inspired fraction of 
oxygen ratio; Ref, reference 
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